EBioMedicine journal (The Lancet) publishes and highlights this month a study on Parkinson's disease carried out by researchers from the IIBB-CSIC

Work led by Dr. Analia Bortolozzi has shown a possible new drug target to alleviate early deficiencies in dopamine function in Parkinson's disease. The results have been confirmed in mice and elderly non-human primates, paving the way to be transferred to humans.

Read More

NEW PUBLICATION: "Cerebro y ejercicio", Dra. Coral Sanfeliu

The book “Cerebro y ejercicio” (“Brain and exercise”) is a new volume in the CSIC collection “¿Qué sabemos de…?” (”What do we know about…?”). This is addressed at a wide reader audience to bring the latest advances in the knowledge of the beneficial effects of physical exercise for the correct functioning of the brain.

Read More


In an invited review published in Seminars Cancer Biology (IF: 11,090), researchers from the group Mitochondrial Regulation of Cell Death, with Dr. Carmen García Ruiz as first author, analyze the role of mitochondrial cholesterol in cancer biology and therapy.

Read More

IIBB researchers organize a Special Issue "Mitochondrial dynamics in neurons"

Dr. Ramon Trullàs and Dr. Anna Colell are currently organizing a Special Issue entitled "Mitochondrial dynamics in neurons", in collaboration with the "International Journal of Molecular Sciences (IJMS)", an open access journal published by MDPI, Switzerland. The aim is to cover research on different aspects of mitochondrial dynamics, mito-nuclear communication, and mitochondrial quality control in neurons, including the influence of glia cells on the function of neuronal mitochondria.

Read More

Design and pre-clinical trial of a new molecule to delay the progression of Parkinson's

The molecule, designed to act only on dopaminergic neurons, reduces the synthesis and accumulation of the alpha-synuclein protein, key in the evolution of the disease. The study, led by the CSIC’s Institute of Biomedical Research of Barcelonaof and IDIBAPS, has obtained promising preliminary results to control its development.

Read More

IIBB-CSIC researchers in cooperation with UB identify a new pharmacological target against Alzheimer’s disease

The new theraputic strategy reduces the inflammation process and de neuronal deterioration in two murine models of the disease.

Read More

The IIBB publishes 5 offers for Ramón y Cajal 2019 candidates

More info and details are available at

Applications deadline: 31/07/2020



Read More